Son d\u00f6nemde pankreas kanseri tedavisinde \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 niteli\u011finde, Massachusetts Teknoloji Enstit\u00fcs\u00fc (MIT) ve Dana-Farber Kanser Enstit\u00fcs\u00fc i\u015f birli\u011fiyle ger\u00e7ekle\u015ftirilen heyecan verici bir ara\u015ft\u0131rmada, pankreas t\u00fcm\u00f6r h\u00fccrelerine \u00f6zg\u00fc yeni bir peptid s\u0131n\u0131f\u0131 ke\u015ffedildi. Bu peptidler, \u201ckriptik peptidler\u201d olarak adland\u0131r\u0131lmakta olup, insan genomunda daha \u00f6nce \u201ckodlamayan\u201d veya sessiz kabul edilen b\u00f6lgelerden t\u00fcremekte. Bu bulgu, pankreas kanserine kar\u015f\u0131 T h\u00fccre arac\u0131l\u0131 imm\u00fcnoterapide yepyeni bir y\u00fczeyi a\u00e7arak, tedavi alan\u0131nda devrim yaratma potansiyeline sahip. Ayr\u0131ca, bu ke\u015fif genomun protein kodlama kapasitesine dair genel alg\u0131y\u0131 da derinden etkilemekte ve normal dokular\u0131 koruyarak sadece t\u00fcm\u00f6r h\u00fccrelerini hedefleyen yeni h\u00fccre bazl\u0131 tedavi yakla\u015f\u0131mlar\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7maktad\u0131r.<\/p>\n
Pankreas duktal adenokarsinomu, k\u00fcresel \u00e7apta en \u00f6l\u00fcmc\u00fcl kanser t\u00fcrlerinden biri olarak kabul edilmekte ve be\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oran\u0131 maalesef %10 civar\u0131nda seyretmektedir. G\u00fcncel tedavi yakla\u015f\u0131mlar\u0131 cerrahi, kemoterapi ve radyoterapiyi birle\u015ftirirken, agresif biyolojik yap\u0131s\u0131 ve erken metastaz yapma e\u011filimi nedeniyle hastal\u0131\u011f\u0131n kontrol alt\u0131na al\u0131nmas\u0131nda \u00f6nemli zorluklar ya\u015fanmaktad\u0131r. Ayr\u0131ca, son y\u0131llarda farkl\u0131 kanser t\u00fcrlerinde devrim yaratan imm\u00fcn kontrol noktas\u0131 inhibit\u00f6rleri, pankreas kanserinde s\u0131n\u0131rl\u0131 ba\u015far\u0131 g\u00f6stermektedir. Bunun arkas\u0131nda yatan en \u00f6nemli nedenlerden biri, t\u00fcm\u00f6r mikro\u00e7evresinin imm\u00fcnosupresif yap\u0131s\u0131 ve hastal\u0131\u011f\u0131n d\u00fc\u015f\u00fck mutasyon y\u00fck\u00fc sebebiyle ba\u011f\u0131\u015f\u0131kl\u0131k sistemince tan\u0131nmas\u0131n\u0131n zor olmas\u0131d\u0131r.<\/p>\n
MIT ve Dana-Farber ara\u015ft\u0131rmac\u0131lar\u0131 bu zorlu durumda imm\u00fcnopeptidomik ad\u0131 verilen sofistike bir y\u00f6ntemden yararlanarak pankreas t\u00fcm\u00f6r h\u00fccre y\u00fczeyinde sunulan peptid spektrumunu ayr\u0131nt\u0131l\u0131 bi\u00e7imde incelemi\u015ftir. Bu y\u00f6ntem, \u00fc\u00e7 boyutlu hasta t\u00fcrevi t\u00fcm\u00f6r organoidlerinden (h\u00fccrelerin do\u011fal t\u00fcm\u00f6r mimarisini ve heterojen yap\u0131s\u0131n\u0131 koruyan laboratuvar ortam\u0131 modelleri) MHC ba\u011flam\u0131nda sunulan peptidlerin do\u011frudan ekstraksiyonunu sa\u011flar. Ard\u0131ndan k\u00fctle spektrometrisi ile binlerce yeni antijen tan\u0131mlanm\u0131\u015ft\u0131r. Dikkat \u00e7ekici bi\u00e7imde, bu antijenlerin b\u00fcy\u00fck bir k\u0131sm\u0131 klasik protein kodlayan gen b\u00f6lgelerinden de\u011fil, genomda \u201ckriptik\u201d olarak adland\u0131r\u0131lan, normalde sessiz veya kodlamayan b\u00f6lgeden gelmi\u015ftir.<\/p>\n
Yakla\u015f\u0131k on iki hasta k\u00f6kenli pankreas t\u00fcm\u00f6r \u00f6rne\u011fi \u00fczerinde yap\u0131lan kapsaml\u0131 analizler, her t\u00fcm\u00f6rde ortalama 250 adet kriptik peptid ifadesi oldu\u011funu g\u00f6stermi\u015ftir. Toplamda ise yakla\u015f\u0131k 1700 farkl\u0131 kriptik peptid tan\u0131mlanm\u0131\u015ft\u0131r. Bu peptidlerin klinik \u00f6nemi, sa\u011fl\u0131kl\u0131 doku \u00f6rnekleri ile kar\u015f\u0131la\u015ft\u0131r\u0131larak de\u011ferlendirilmi\u015f ve yakla\u015f\u0131k 500 peptidin sadece malign pankreas h\u00fccrelerinde bulunup \u00e7e\u015fitli normal dokularda yer almad\u0131\u011f\u0131 tespit edilmi\u015ftir. Bu durum, bu peptidleri t\u00fcm\u00f6r-h\u00fccreye \u00f6zg\u00fc ve potansiyel hedef molek\u00fcller olarak g\u00f6stermektedir.<\/p>\n
Bu \u00f6zg\u00fcn peptidlerin imm\u00fcnojenik potansiyelini test etmek amac\u0131yla se\u00e7ilen epitopler sentezlenmi\u015f ve kontroll\u00fc laboratuvar ortam\u0131nda olgunla\u015fmam\u0131\u015f T h\u00fccrelerine sunulmu\u015ftur. Sonu\u00e7lar, test edilen peptidlerin yakla\u015f\u0131k yar\u0131s\u0131na kar\u015f\u0131 g\u00fc\u00e7l\u00fc klonal T h\u00fccre \u00e7o\u011falmas\u0131 ve T h\u00fccre resept\u00f6r (TCR) etkinle\u015ftirilmesi ortaya koymu\u015ftur. Ayr\u0131ca, bu peptidlere \u00f6zg\u00fc TCR\u2019ler kodlayan genetik olarak tasarlanm\u0131\u015f T h\u00fccreler geli\u015ftirilmi\u015f ve b\u00f6ylece pankreas t\u00fcm\u00f6r h\u00fccrelerini \u00f6zg\u00fcl olarak tan\u0131yan ve hedef alan T h\u00fccrelerin \u00fcretimi sa\u011flanm\u0131\u015ft\u0131r.<\/p>\n
Bu genetik olarak modifiye edilen T h\u00fccrelerin fonksiyonel etkisi hem organoid k\u00fclt\u00fcrlerinde hem de fare modellerinde test edilmi\u015ftir. Organoid deneylerinde, bu T h\u00fccreleri t\u00fcm\u00f6r h\u00fccrelerinde belirgin sitotoksisite yaratm\u0131\u015f ve canl\u0131 t\u00fcm\u00f6r h\u00fccresi say\u0131s\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde azaltm\u0131\u015ft\u0131r. Ayr\u0131ca, imm\u00fcns\u00fcpresif fare modellerinde insan k\u00f6kenli pankreas t\u00fcm\u00f6r organoidlerinin implantasyonunu takiben uygulanan bu tedavi, t\u00fcm\u00f6r b\u00fcy\u00fcmesinde anlaml\u0131 bir yava\u015flama sa\u011flam\u0131\u015ft\u0131r. Bu bulgular, bu imm\u00fcnoterapi stratejisinin klinik uygulama potansiyelini desteklemektedir.<\/p>\n
Yine de, bu \u00f6n klinik \u00e7al\u0131\u015fmalar\u0131n tamam\u0131nda t\u00fcm\u00f6rlerin tamamen ortadan kalkmad\u0131\u011f\u0131 g\u00f6zlemlenmi\u015ftir. Ancak, mevcut T h\u00fccresi tedavileri t\u00fcm\u00f6r b\u00fcy\u00fcmesini anlaml\u0131 bi\u00e7imde engelledi\u011finden, ek stratejilerle T h\u00fccrelerinin kal\u0131c\u0131l\u0131\u011f\u0131n\u0131n ve etkinli\u011finin art\u0131r\u0131lmas\u0131 halinde klinik faydan\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde y\u00fckselebilece\u011fi \u00fcmit edilmektedir. Ara\u015ft\u0131rmac\u0131lar \u00f6zellikle TCR\u2019lerin afinitesinin optimize edilmesi ve kombine yakla\u015f\u0131mlar\u0131n kullan\u0131lmas\u0131 ile tedavi ba\u015far\u0131s\u0131n\u0131n art\u0131r\u0131lmas\u0131n\u0131 hedeflemektedir.<\/p>\n
Kriptik peptid ke\u015ffi sadece h\u00fccre terapileri i\u00e7in de\u011fil, ayn\u0131 zamanda olas\u0131 kanser a\u015f\u0131lar\u0131 geli\u015ftirilmesi i\u00e7in de sa\u011flam bir temel olu\u015fturmaktad\u0131r. Ara\u015ft\u0131rma ekibi, \u00e7ok say\u0131da hastaya \u00f6zg\u00fc ortak kriptik peptid epitoplar\u0131n\u0131 kapsayan a\u015f\u0131 form\u00fclasyonlar\u0131 \u00fczerinde \u00e7al\u0131\u015fmakta, bu sayede ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin pankreas t\u00fcm\u00f6rlerini sistemik olarak hedeflemesi ama\u00e7lanmaktad\u0131r. Bu a\u015f\u0131 yakla\u015f\u0131mlar\u0131, hastalarda kal\u0131c\u0131 ve etkili imm\u00fcn yan\u0131t olu\u015fturma potansiyeline sahiptir.<\/p>\n
Ayr\u0131ca, bu \u00e7al\u0131\u015fman\u0131n bulgular\u0131 \u00e7ift spesifik T h\u00fccre ba\u011flay\u0131c\u0131 antikorlar (bispecific T cell engagers) geli\u015ftirmek i\u00e7in de \u00f6nem ta\u015f\u0131maktad\u0131r. Bu biyoteknolojik bile\u015fikler, T h\u00fccrelerini t\u00fcm\u00f6r antijenlerine fiziksel olarak ba\u011flayarak, genetik m\u00fchendislik gerektirmeden h\u0131zl\u0131 ve etkili t\u00fcm\u00f6r h\u00fccresi \u00f6ld\u00fcrme yetene\u011fi kazand\u0131rmaktad\u0131r. Kriptik peptidlere y\u00f6nelik engelleyiciler, geni\u015f hasta gruplar\u0131n\u0131n yararlanabilece\u011fi kullan\u0131ma haz\u0131r imm\u00fcnoterap\u00f6tik se\u00e7enekler sunabilir.<\/p>\n
Bu paradigm de\u011fi\u015ftiren \u00e7al\u0131\u015fma, pankreas t\u00fcm\u00f6rlerinin proteogenomik zenginli\u011fini kullanarak \u015fimdiye kadar ke\u015ffedilmemi\u015f bir antijenik repertuar\u0131 ortaya koymu\u015f ve pankreas kanserine \u00f6zg\u00fc molek\u00fcler i\u015faretlerin hedef al\u0131nd\u0131\u011f\u0131 yeni nesil imm\u00fcnoterapilerin yolunu a\u00e7m\u0131\u015ft\u0131r. Klinik uygulamalar hen\u00fcz ba\u015flang\u0131\u00e7 a\u015famas\u0131nda olmas\u0131na ra\u011fmen, bu yakla\u015f\u0131m\u0131n g\u00fcvenlik, \u00f6zg\u00fcll\u00fck ve terap\u00f6tik etkinli\u011finin art\u0131r\u0131lmas\u0131 i\u00e7in yo\u011fun \u00e7abalar s\u00fcrmektedir.<\/p>\n
Ara\u015ft\u0131rma, Hale Family Center for Pancreatic Cancer Research, Lustgarten Foundation, Stand Up To Cancer ve Amerika Ulusal Sa\u011fl\u0131k Enstit\u00fcleri (NIH) gibi sayg\u0131n kanser ara\u015ft\u0131rmalar\u0131 fonlar\u0131 taraf\u0131ndan desteklenmi\u015ftir. Proje, genomik, proteomik ve imm\u00fcnolojik alanlar\u0131n bir araya geldi\u011fi i\u015fbirlik\u00e7i ve disiplinleraras\u0131 \u00e7al\u0131\u015fmalar\u0131n ba\u015far\u0131l\u0131 bir \u00f6rne\u011fidir. B\u00f6ylece, uzun s\u00fcredir zorlu tedavi problemleriyle ba\u015f etmeye \u00e7al\u0131\u015fan pankreas kanserinde umut vaat eden \u00f6nemli bir ad\u0131m haline gelmi\u015ftir.<\/p>\n
Sonu\u00e7 olarak, pankreas kanserine \u00f6zg\u00fc kriptik antijenlerin tan\u0131mlanmas\u0131, kanser imm\u00fcnolojisi alan\u0131ndaki geleneksel anlay\u0131\u015f\u0131 sarsmakta ve ki\u015fiye \u00f6zel T h\u00fccre tedavileri ve a\u015f\u0131 geli\u015ftirilmesi i\u00e7in yenilik\u00e7i bir yol a\u00e7maktad\u0131r. T\u00fcm\u00f6r\u00fcn gizli kalan bu antijenik katman\u0131n\u0131n hedef al\u0131nmas\u0131, kal\u0131c\u0131 ve etkili bir imm\u00fcn yan\u0131t ile pankreas kanserinde uzun vadeli kontrol\u00fcn sa\u011flanmas\u0131 ve hasta sa\u011fkal\u0131m\u0131n\u0131n art\u0131r\u0131lmas\u0131 a\u00e7\u0131s\u0131ndan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 olabilir.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Haberin Yay\u0131n Tarihi<\/strong>: Web References<\/strong>: Anahtar Kelimeler<\/strong>: Son d\u00f6nemde pankreas kanseri tedavisinde \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 niteli\u011finde, Massachusetts Teknoloji Enstit\u00fcs\u00fc (MIT) ve Dana-Farber Kanser Enstit\u00fcs\u00fc i\u015f birli\u011fiyle ger\u00e7ekle\u015ftirilen heyecan verici bir ara\u015ft\u0131rmada, pankreas t\u00fcm\u00f6r h\u00fccrelerine \u00f6zg\u00fc yeni bir peptid s\u0131n\u0131f\u0131 ke\u015ffedildi. Bu peptidler, \u201ckriptik peptidler\u201d olarak adland\u0131r\u0131lmakta olup, insan genomunda daha \u00f6nce \u201ckodlamayan\u201d veya sessiz kabul edilen b\u00f6lgelerden t\u00fcremekte. Bu bulgu, pankreas…<\/p>\n","protected":false},"author":1,"featured_media":5241,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[6500,6498,6499,6496,6497],"tmauthors":[],"class_list":{"0":"post-5240","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-immunopeptidomik-yontemi-pankreas-kanseri","9":"tag-kriptik-peptidler-pankreas-tumor-hucreleri","10":"tag-pankreas-duktal-adenokarsinom-tedavi-zorluklari","11":"tag-pankreas-kanseri-yeni-tedavi-hedefleri","12":"tag-pankreas-kanserinde-immunoterapi-yaklasimlari"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/Pankreas-Kanseri-Icin-Yeni-Tedavi-Hedefleri-1746733546.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5240"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5240\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5241"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5240"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPankreas kanserine \u00f6zg\u00fc kriptik peptidler ve bunlar\u0131n T h\u00fccresi tan\u0131ma ve imm\u00fcnoterapi hedefleri olarak kullan\u0131lmas\u0131.<\/p>\n
\nPancreatic cancer-restricted cryptic antigens are targets for T cell recognition<\/p>\n
\n8-May\u0131s-2025<\/p>\n
\nDOI: 10.1126\/science.adk3487<\/p>\n
\nPankreas kanseri, kriptik peptidler, imm\u00fcnopeptidomik, T h\u00fccre tedavisi, kanser imm\u00fcnoterapisi, h\u00fccre transfer tedavisi, peptidler, h\u00fccre tedavileri, kanser tedavileri, a\u015f\u0131 ara\u015ft\u0131rmalar\u0131, kanser ara\u015ft\u0131rmalar\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"